Protein detail

CC112

Coiled-coil domain-containing protein 112 (Mutated in bladder cancer protein 1)

Entry name
CC112
UniProt ID
EVMP confidence score
0.38
Supporting publications (n)
2
Transmembrane count
Protein classification
Predicted intracellular proteins
EVMP confidence score

Annotation confidence score; open for threshold definitions.

Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
Basic Information11
Protein Names
Coiled-coil domain-containing protein 112 (Mutated in bladder cancer protein 1)
Protein Class
Predicted intracellular proteins
Protein Function
Predicted intracellular proteins
Entrez Gene Symbol
Gene Synonym
MGC39633
Gene Description
Coiled-coil domain containing 112
Chromosome
5
Position
115267190-115296693
Supporting publications (n)
2
EVMP confidence score
0.38
Fluorescence & Localization1
Cell SpecificEsophageal apical cells
Function & Pathway5
Relations & Evidence10

Ligand-Receptor Signaling (6)

6 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
intracellularintracellularComPPINoNoYesNoNo
intracellularintracellularGO_IntercellNoNoYesNoNo
intracellularintracellularUniProt_locationNoNoYesNoNo
intracellularintracellularOmniPathNoNoYesNoNo
secretedsecretedHPA_secretomeNoNoYesNoNo
secretedsecretedOmniPathNoNoYesNoNo

Protein Complex Composition (3)

3 records.

Component NameComponent Gene SymbolsComponent UniProt IDStoichiometryDatabaseDatabase IDsReferences
CCDC112NOL4TEX9O94818Q8N6V9Q8NEF30:0:0hu.MAP2
CCDC112NOL4NOL4LTEX9O94818Q8N6V9Q8NEF3Q96MY10:0:0:0hu.MAPhu.MAP2
CCDC112NOL4LTEX9Q8N6V9Q8NEF3Q96MY10:0:0hu.MAPhu.MAP2

Isolation & Detection Technology (1)

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Differential UltracentrifugationUltrafiltration / Tangential Flow FiltrationSize Exclusion ChromatographyImmunoaffinity CaptureMass spectrometryMass spectrometry [LTQ-FT Ultra]R Sequencing2540985879379267564083128036064647381133682868015237322475401894974106825333592500328543153447350532560723329169864130796836146834333098263860706232230970382071063457624637204515390017003920704738590132
Sequence, Structure & Domains8

Sequences

Length
446
Mass
53,565
Sequence
MEKDKHSHFYNQKSDFRIEHSMLEELENKLIHSRKTERAKIQQQLAKIHNNVKKLQHQLKDVKPTPDFVEKLREMMEEIENAINTFKEEQRLIYEELIKEEKTTNNELSAISRKIDTWALGNSETEKAFRAISSKVPVDKVTPSTLPEEVLDFEKFLQQTGGRQGAWDDYDHQNFVKVRNKHKGKPTFMEEVLEHLPGKTQDEVQQHEKWYQKFLALEERKKESIQIWKTKKQQKREEIFKLKEKADNTPVLFHNKQEDNQKQKEEQRKKQKLAVEAWKKQKSIEMSMKCASQLKEEEEKEKKHQKERQRQFKLKLLLESYTQQKKEQEEFLRLEKEIREKAEKAEKRKNAADEISRFQERDLHKLELKILDRQAKEDEKSQKQRRLAKLKEKVENNVSRDPSRLYKPTKGWEERTKKIGPTGSGPLLHIPHRAIPTWRQGIQRRV
Alternative Products
Event=Alternative splicing; Named isoforms=2; Name=1; IsoId=Q8NEF3-1; Sequence=Displayed; Name=2; IsoId=Q8NEF3-2; Sequence=VSP_031624
Alternative Sequence
1; M -> MAALTTVVVAAAATAVAGAVAGAGAATGTGVGATPAPQQSDGCFSTSGGIRPFHLQNWKQKVNQTKKAEFVRTAEKFKNQVINM (in isoform 2)

Domain & Motif Annotations

Compositional Bias
255..268; Basic and acidic residues
Coiled Coil
35..116; 219..400
Region
253..272; Disordered; 390..430; Disordered
Clinical Relevance4
Interaction Protein (2)
ENSG00000151575ENSG00000171357
Interaction Count
2
Interaction Dataset
intact_biogrid
Supporting Publications2
PMIDTitleAbstract
36741391Circulating exosomal immuno-oncological checkpoints and cytokines are potential biomarkers to monitor tumor response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients.We have also shown that immuno-oncological proteins isolated from pre-ICIs treated patients were significantly higher in exosomes compared to their soluble-free counterparts (CD152, p=0.0008; CD80, p=0.0182; IDO, p=0.0443; Arginase, p<0.0001; Nectin-2, p<0.0001; NT5E, p<0.0001; Siglec-7, p<0.0001; Siglec-9, p=0.0335; CD28, p=0.0092; GITR, p<0.0001; MICA, p<0.0001).
37547182Retroviral b-Zip protein (HBZ) contributes to the release of soluble and exosomal immune checkpoint molecules in the context of neuroinflammation.For the very first time, we demonstrate a unique elevated presence of several stimulatory (CD27, CD28, 4-1BB) and inhibitory (BTLA, CTLA-4, LAG-3, PD-1, PD-L2) ICP receptors in HAM/TSP sera, and in purified exosomes from a HAM/TSP-derived HTLV-1-producing (OSP2) cells.